hrcak mascot   Srce   HID

Other

Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice

Petar Kes
Vanja Bašić-Kes
Nikolina Bašić-Jukić
Vida Demarin

Fulltext: english, pdf (227 KB) pages 137-153 downloads: 927* cite
APA 6th Edition
Kes, P., Bašić-Kes, V., Bašić-Jukić, N. & Demarin, V. (2012). Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice. Acta clinica Croatica, 51 (1), 137-153. Retrieved from https://hrcak.srce.hr/85749
MLA 8th Edition
Kes, Petar, et al. "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice." Acta clinica Croatica, vol. 51, no. 1, 2012, pp. 137-153. https://hrcak.srce.hr/85749. Accessed 7 May 2021.
Chicago 17th Edition
Kes, Petar, Vanja Bašić-Kes, Nikolina Bašić-Jukić and Vida Demarin. "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice." Acta clinica Croatica 51, no. 1 (2012): 137-153. https://hrcak.srce.hr/85749
Harvard
Kes, P., et al. (2012). 'Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice', Acta clinica Croatica, 51(1), pp. 137-153. Available at: https://hrcak.srce.hr/85749 (Accessed 07 May 2021)
Vancouver
Kes P, Bašić-Kes V, Bašić-Jukić N, Demarin V. Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice. Acta clinica Croatica [Internet]. 2012 [cited 2021 May 07];51(1):137-153. Available from: https://hrcak.srce.hr/85749
IEEE
P. Kes, V. Bašić-Kes, N. Bašić-Jukić and V. Demarin, "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice", Acta clinica Croatica, vol.51, no. 1, pp. 137-153, 2012. [Online]. Available: https://hrcak.srce.hr/85749. [Accessed: 07 May 2021]

Abstracts
Therapeutic plasma exchange (TPE ) is a well-established therapeutic procedure commonly used in many neurologic immune-mediated disorders. It is thought that the beneficial effects of TPE occur through elimination of pathognomonic autoantibodies, immune complexes, inflammatory mediators, complement components and cytokines, which play a crucial role in many kinds of neurologic autoimmune disease. In various neurologic disorders, randomized controlled studies have demonstrated the efficacy of TPE (e.g., in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome), chronic inflammatory demyelinating polyradiculoneuropathy, myasthenia gravis and paraproteinemic polyneuropathies). For these disorders, TPE is accepted as first-line therapy, either as a primary standalone treatment or in conjunction with other modes of treatment. Although widely used, the potential benefit of TPE in the treatment of acute disseminated encephalomyelitis, chronic focal encephalitis (Rasmussen’s encephalitis), Lambert-Eaton myasthenic syndrome, multiple sclerosis and neuromyelitis optica (Devic’s disease) is less clear. For these disorders, TPE is accepted as second-line therapy, either as a standalone treatment or in conjunction with other modes of treatment.

Keywords
Acute disseminated encephalomyelitis; Acute inflammatory demyelinating polyneuropathy; Chronic focal encephalitis; Chronic inflammatory demyelinating polyradiculoneuropathy; Lambert-Eaton myasthenic syndrome; Multiple sclerosis; Myasthenia gravis; Neuromyelitis optica; Paraproteinemic polyneuropathies; Therapeutic plasma exchange

Hrčak ID: 85749

URI
https://hrcak.srce.hr/85749

[croatian]

Visits: 1.950 *